Science

Discovery

Small molecules are the optimal therapeutic modality for expanding the druggable universe and improving healthspan for patients and caregivers. The continuous collaboration between our medicinal chemistry, translational biology, platform discovery, computational science, and pharmacology groups fuels our innovative pipeline

Breakthrough Research in Small Molecule Therapies

Small molecules that achieve significant and deep brain penetration occupy a privileged chemical property space.

Molecules in this space often carry beneficial properties (stability, safety, etc) that enable us to create best-in-class molecules both for CNS and non-CNS applications.

Our experienced team has demonstrated ability to efficiently develop molecules in this space and deliver the promise of small molecules to patients in need.